Home › Funds › EMERALD MUTUAL FUND ADVISERS TRUST › MIRM

EMERALD MUTUAL FUND ADVISERS TRUST position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

EMERALD MUTUAL FUND ADVISERS TRUST reported holding 281,185 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$24.0M, representing 0.98% of its reported portfolio and ranking #36 among its reported holdings. EMERALD MUTUAL FUND ADVISERS TRUST has disclosed MIRM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)281.19K sh
Reported value held$24.04M
Portfolio Weight0.98%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EMERALD MUTUAL FUND ADVISERS TRUST's MIRM position evolved

EMERALD MUTUAL FUND ADVISERS TRUST first disclosed a stake in MIRM in Q2 2025 at 217,542 shares (US$11.1M). The position peaked in Q2 2026 at 289,372 shares, worth US$33.9M. Across 6 filings, EMERALD MUTUAL FUND ADVISERS TRUST increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 281,185 shares valued at US$24.0M — a reduction of -8,187 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2025 217.54K $11.07M New
Q3 2025 219.04K $16.06M Add
Q4 2025 242.32K $19.14M Add
Q1 2026 250.40K $23.13M Add
Q2 2026 289.37K $33.88M Add
Q3 2026 281.19K $24.04M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has EMERALD MUTUAL FUND ADVISERS TRUST held MIRM?

EMERALD MUTUAL FUND ADVISERS TRUST has disclosed MIRM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is EMERALD MUTUAL FUND ADVISERS TRUST's current position in MIRM?

As of Q3 2026, EMERALD MUTUAL FUND ADVISERS TRUST holds 281.19K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $24.04M, representing 0.98% of its reported portfolio and ranking #36.

Has EMERALD MUTUAL FUND ADVISERS TRUST been buying or selling MIRM?

In the latest 13F filing (Q3 2026), EMERALD MUTUAL FUND ADVISERS TRUST reduced its position in MIRM. The position peaked in Q2 2026 at 289.37K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.